IMAX CORP

Listed Company

IMAXCIK 0000921582NYSELarge AcceleratedPhotographic Equipment & SuppliesA6CAFY ends Dec 31

Period

FY 2025

Revenue

$410.21M

Net Income

$34.88M

Total Assets

$894.03M

Equity

$337.89M

Shares Out

54.86M

Op. Cash Flow

$127.07M

IMAX$39.24+37.47% · past yearDBEQ Basic

Daily closing prices

Business

IMAX Corporation is a global technology platform for entertainment and events that develops proprietary projection, sound, and auditorium systems for premium cinema experiences. The company generates revenue from digital remastering of films into IMAX format, distribution of documentary and event content, sale and lease of IMAX theater systems to exhibitors, and ongoing maintenance services. Operating segments serve two distinct customer bases: Content Solutions focuses on movie studios and content creators, while Technology Products and Services targets commercial multiplex exhibitors, institutional customers, and destination entertainment sites across 91 countries.

Summary from 10-K filed 2026-02-25

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	410	352	375	301	255
Total Costs and Expenses Applicable to Revenues	164	162	160	144	120
Gross margin	246	190	214	156	134
Selling, general and administrative expenses	138	133	144	138	117
Research and development	6	5	10	5	7
Amortization of intangible assets	8	6	5	5	5
Credit loss expense (reversal), net	696,000	−973,000	2	9	—
Asset impairments	0	0	144,000	—	—
Goodwill impairment	7	0	0	—	—
Restructuring charges and other impairments	3	4	3	0	—
Income from operations	84	44	50	−5	11
Realized and unrealized investment (losses) gains	−867,000	127,000	465,000	70,000	5
Retirement benefits non-service expense	−243,000	−387,000	−411,000	−556,000	−463,000
Interest income	3	2	2	1	—
Interest expense	−7	−8	−7	−6	—
Induced conversion expense on settlement on convertible notes	−15	0	0	—	—
Income before taxes	63	38	46	−10	11
Income tax expense	−18	−5	−13	−10	−21
Net income	46	33	33	−20	−10
Net income attributable to non-controlling interests	−11	−7	−8	−3	−13
Net income attributable to common shareholders	35	26	25	−23	−22
Basic (in dollars per share)	0.65	0.49	0.47	−0.4	−0.38
Diluted (in dollars per share)	0.63	0.48	0.46	−0.4	−0.38
Basic (in shares)	54	53	54	57	59
Diluted (in shares)	56	54	55	57	59

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	151	101	76	97	190
Accounts receivable, net of allowance for credit losses	108	108	136	136	110
Financing receivables, net of allowance for credit losses	122	120	127	—	—
Variable consideration receivables, net of allowance for credit losses	91	83	64	44	44
Inventories	33	33	32	32	27
Prepaid expenses	15	13	12	12	12
Film assets, net of accumulated amortization	16	9	7	5	4
Property, plant and equipment, net of accumulated depreciation	243	240	243	253	260
Other assets	25	22	21	16	18
Deferred income tax assets, net of valuation allowance	13	14	8	10	14
Goodwill	46	53	53	53	39
Other intangible assets, net of accumulated amortization	32	35	35	33	23
Total assets	894	830	815	821	883
Accounts payable	19	20	26	25	16
Accrued and other liabilities	105	101	111	117	112
Deferred revenue	50	53	67	71	81
Revolving credit facility borrowings, net of unamortized debt issuance costs	35	36	23	36	2
Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs	244	230	229	227	224
Deferred income tax liabilities	13	13	13	15	18
Total liabilities	466	452	469	491	453
Commitments, contingencies and guarantees (see Notes 14 and 15)	—	—	—	—	—
Non-controlling interests	666,000	680,000	658,000	722,000	758,000
Capital stock common shares no par value. Authorized Unlimited number. 53,921,676 issued and outstanding (December 31, 2024 52,946,200 issued and outstanding)	419	401	389	377	410
Other equity	165	185	185	186	175
Statutory surplus reserve	4	4	4	4	4
Accumulated deficit	−240	−275	−293	−293	−235
Accumulated other comprehensive loss	−10	−17	−12	−10	3
Total shareholders equity attributable to common shareholders	338	299	273	263	356
Non-controlling interests	89	78	72	66	74
Total shareholders equity	427	378	345	329	430
Total liabilities and shareholders equity	894	830	815	821	883

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	62	66	60	57	56
Amortization of deferred financing costs	2	2	2	3	3
Write-downs, including goodwill and asset impairments	9	4	2	7	2
Deferred income tax expense (benefit)	772,000	−6	−1	−2	3
Share-based and other non-cash compensation	27	23	24	28	26
Unrealized foreign currency exchange gain	−134,000	−3	−212,000	1	256,000
Accounts receivable	−1	29	−2	−29	−52
Inventories	−76,000	−2	−285,000	−6	11
Film assets	−25	−25	−20	−20	−15
Deferred revenue	−2	−14	−4	−12	−7
Changes in other operating assets and liabilities	−7	−35	−36	801,000	−2
Net cash provided by operating activities	127	71	59	17	6
Purchase of property, plant and equipment	−8	−8	−6	−8	−4
Investment in equipment for joint revenue sharing arrangements	−28	−24	−18	−20	−10
Acquisition of other intangible assets	−5	−8	−8	−4	−4
Proceeds from sale of equity securities	0	0	1	0	18
Net cash used in investing activities	−42	−41	−32	−53	−7,000
Proceeds from issuance of convertible notes, net	243	0	0	—	224
Redemption of capped calls related to convertible notes	31	0	0	—	—
Debt issuance costs related to convertible notes	−24,000	0	0	—	−1
Cash paid related to repurchase of convertible notes	−275	0	0	—	—
Purchase of capped calls related to convertible notes	−22	0	0	—	−19
Proceeds from revolving credit facility borrowings	109	55	40	38	4
Repayments of revolving credit facility borrowings	−109	−42	−53	−4	−308
Proceeds from other borrowings	0	0	322,000	0	—
Repayment of other borrowings	−1	−874,000	−53,000	0	—
Credit facility amendment fees paid	−2	0	−46,000	−2	−527,000
Taxes withheld and paid on employee stock awards vested	−10	−5	−6	−4	−4
Common shares issued - stock options exercised	4	5	0	0	883,000
Principal payment under finance lease obligations	0	−509,000	−480,000	−948,000	—
Dividends paid to non-controlling interests	0	0	−1	−3	−5
Net cash used in financing activities	−34	−6	−49	−59	−133
Effects of exchange rate changes on cash	−497,000	812,000	504,000	2	−1
Increase (decrease) in cash and cash equivalents during year	51	24	−21	−92	−128

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is IMAX CORP's CIK number?

IMAX CORP's SEC CIK number is 0000921582 (921582). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find IMAX CORP's SEC filings?

All of IMAX CORP's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did IMAX CORP last report earnings?

IMAX CORP (IMAX) most recently filed an earnings 8-K with the SEC on Apr 30, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-028907). This is IMAX CORP's most recent earnings filing of record — not a forecast of its next earnings date.

What is IMAX CORP's most recent earnings 8-K?

IMAX CORP's latest earnings 8-K (Item 2.02) was filed Apr 30, 2026 under accession 0001628280-26-028907. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View IMAX CORP's latest earnings 8-K →
Look up any company's CIK number →